Cancer risk associated with DPP4 inhibitors in type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS)

• Wan Xiong,

  Roles Conceptualization, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliations Department of Pharmacy, The First Hospital of Changsha, Changsha, China, Department of Pharmacy, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, China

  https://orcid.org/0009-0001-8211-7020

  ⨯
• Yilin Li,

  Roles Data curation, Software, Validation, Writing – original draft, Writing – review & editing

  Affiliation Department of Information and Digital Technology, PowerChina Zhongnan Engineering Corporation Limited, Changsha, China

  ⨯
• Juanjuan Huang,

  Roles Funding acquisition, Validation, Writing – original draft, Writing – review & editing

  Affiliations Department of Pharmacy, The First Hospital of Changsha, Changsha, China, Department of Pharmacy, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, China

  ⨯
• Gefei He,

  Roles Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing

  Affiliations Department of Pharmacy, The First Hospital of Changsha, Changsha, China, Department of Pharmacy, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, China

  ⨯
• Ji Sun

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Writing – review & editing

  * E-mail: sunjifigting2021@163.com

  Affiliations Department of Pharmacy, The First Hospital of Changsha, Changsha, China, Department of Pharmacy, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, China

  https://orcid.org/0009-0005-6370-9740

  ⨯